LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
33 hedge funds and large institutions have $22.4M invested in LYRA THERAPEUTICS INC in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 8 closing their positions.
0.24% less ownership
Funds ownership: 1.03% → 0.79% (-0.24%)
6% less funds holding
Funds holding: 35 → 33 (-2)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
63% less capital invested
Capital invested by funds: $60.8M → $22.4M (-$38.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
+$417K |
| 2 |
Renaissance Technologies
New York
|
+$334K |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$253K |
| 4 |
Millennium Management
New York
|
+$224K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$85.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.32M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.27M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.11M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$697K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$171K |
LYRA Hedge Fund Activity: Q4 2021 in Review
33 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q4 2021, worth a combined $22.4M — down 63% from $60.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LYRA and 7 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 6 added.
The largest buyer was Clearline Capital, opening a new position worth an estimated $417K. The largest seller was Soleus Capital Management, cutting an estimated $1.32M.
- 33 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q4 2021, down from 35 in Q3 2021.
- Funds reported $22.4M of LYRA THERAPEUTICS INC stock for Q4 2021, down 63% quarter-over-quarter.
- 7 funds opened new LYRA THERAPEUTICS INC positions in Q4 2021 and 8 closed out, a net change of -1 holder.
- The largest LYRA THERAPEUTICS INC buyer in Q4 2021 was Clearline Capital, an estimated $417K added.
- The largest LYRA THERAPEUTICS INC seller in Q4 2021 was Soleus Capital Management, an estimated $1.32M sold.
Based on aggregated 13F filings for Q4 2021.